Associations - HER-2 L869R

BIOMARKER:

HER-2 L869R

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

HER-2 L869R HER-2 L869R	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	neratinib + ado-trastuzumab emtansine Sensitive: D – Preclinical neratinib + ado-trastuzumab emtansine Sensitive : D
HER-2 L869R HER-2 L869R	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	neratinib + fam-trastuzumab deruxtecan-nxki Sensitive: D – Preclinical neratinib + fam-trastuzumab deruxtecan-nxki Sensitive : D
HER-2 L869R HER-2 L869R	Breast Cancer Breast Cancer	ado-trastuzumab emtansine Resistant: D – Preclinical ado-trastuzumab emtansine Resistant : D